Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Nov;67(11):1321-5.
doi: 10.6061/clinics/2012(11)17.

Biomarkers in community-acquired pneumonia: a state-of-the-art review

Renato Seligman  1 , Luis Francisco Ramos-Lima, Vivian do Amaral Oliveira, Carina Sanvicente, Elyara F Pacheco, Karoline Dalla Rosa
Affiliations
Review

Biomarkers in community-acquired pneumonia: a state-of-the-art review

Renato Seligman et al. Clinics (Sao Paulo). 2012 Nov.

Abstract

Community-acquired pneumonia (CAP) exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for searching for antibiotic therapy modifications and for CAP diagnosis, prognosis and follow-up treatment. This non-systematic state-of-the-art review presents the biological and clinical features of biomarkers in CAP patients, including procalcitonin, C-reactive protein, copeptin, pro-ANP (atrial natriuretic peptide), adrenomedullin, cortisol and D-dimers.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. National Center for Health Statistics. Health Statistics. 2006
    1. Bauer TT, Welte T, Ernen C, Schlosser BM, Thate-Waschke I, de Zeeuw J, et al. Cost analyses of community-acquired pneumonia from the hospital perspective. Chest. 2005;128(4):2238–46. - PubMed
    1. Riley PD, Aronsky D, Dean NC. Validation of the 2001 American Thoracic Society criteria for severe community-acquired pneumonia. Crit Care Med. 2004;32(12):2398–402. - PubMed
    1. Moine P, Vercken JB, Chevret S, Chastang C, Gajdos P. Severe community-acquired pneumonia.Etiology, epidemiology, and prognosis factors. French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit. Chest. 1994;105(5):1487–95. - PubMed
    1. Woodhead MA, Macfarlane JT, Rodgers FG, Laverick A, Pilkington R, Macrae AD. Aetiology and outcome of severe community-acquired pneumonia. J Infect. 1985;10(3):204–10. - PubMed